- Home
- SAFE vs YDES Comparison
SAFE vs YDES Comparison
Compare SAFE & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFE
- YDES
- Stock Information
- Founded
- SAFE 2016
- YDES 2013
- Country
- SAFE United States
- YDES Taiwan
- Employees
- SAFE N/A
- YDES N/A
- Industry
- SAFE Real Estate Investment Trusts
- YDES
- Sector
- SAFE Real Estate
- YDES
- Exchange
- SAFE Nasdaq
- YDES Nasdaq
- Market Cap
- SAFE 1.2B
- YDES 1.1B
- IPO Year
- SAFE 2017
- YDES N/A
- Fundamental
- Price
- SAFE $13.36
- YDES $12.90
- Analyst Decision
- SAFE Buy
- YDES
- Analyst Count
- SAFE 9
- YDES 0
- Target Price
- SAFE $19.56
- YDES N/A
- AVG Volume (30 Days)
- SAFE 455.4K
- YDES 80.6K
- Earning Date
- SAFE 11-05-2025
- YDES 09-30-2025
- Dividend Yield
- SAFE 5.28%
- YDES N/A
- EPS Growth
- SAFE N/A
- YDES N/A
- EPS
- SAFE 1.57
- YDES N/A
- Revenue
- SAFE $398,968,000.00
- YDES $510,360.00
- Revenue This Year
- SAFE $0.58
- YDES N/A
- Revenue Next Year
- SAFE $4.98
- YDES N/A
- P/E Ratio
- SAFE $8.54
- YDES N/A
- Revenue Growth
- SAFE 2.96
- YDES 45.76
- 52 Week Low
- SAFE $12.83
- YDES $5.30
- 52 Week High
- SAFE $21.90
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- SAFE 35.38
- YDES N/A
- Support Level
- SAFE $12.87
- YDES N/A
- Resistance Level
- SAFE $13.78
- YDES N/A
- Average True Range (ATR)
- SAFE 0.57
- YDES 0.00
- MACD
- SAFE -0.10
- YDES 0.00
- Stochastic Oscillator
- SAFE 17.24
- YDES 0.00
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.